Using Salomon et al. (2021) and Prasher & Janicki Ch. 16, discuss: (1) What are the most pressing risks of polypharmacy in this population?
Using Salomon et al. (2021) and Prasher & Janicki Ch. 16, discuss: (1) What are the most pressing risks of polypharmacy in this population? (2) How should interdisciplinary teams navigate ethical tensions between behavioral control, quality of life, and informed consent for individuals who may...